GOLPH3: a novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancer
Shicong Tang(Tumor Hospital of Guangxi Medical University), Rirong Yang, Huawei Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianlun Liu(Tumor Hospital of Guangxi Medical University), Wei Wei(Zhujiang Hospital), Hong Pan(Binzhou Medical University)
Cited by 24
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
|European Journal of Endocrinology|2011|160